The increasing impact of cancer on worldwide mortality makes the research of novel
chemotherapeutic agents a current and challenging issue. In the recent years, transition …

Molecular hydrogen (H 2) is one of the future energy carriers when replacing fossil sources.
Enzymatic systems serve as an inspiration for the design of novel hydrogen evolving …

Bimetallic µ-bridged complexes supported by macrocycles are worth addressing due to their
excellent stability, rich redox chemistry and suitability in catalysis. This paper for the first-time …

We report an extensive study of axial ligand replacement in ruthenium (II) complexes with
tetra-tert-butyl-phthalocyanine (tBu 4 Pc). For this purpose oxidative decarbonylation of [tBu …

Phthalocyanine (Pc) dyes are photoactive molecules that can absorb and emit light in the
visible spectrum, especially in the red region of the spectrum, with great potential for …

A series of mononuclear ruthenium (II) tetra-tert-butyl-phthalocyaninates bearing axial N-
donor ligands [t Bu4PcRu] L2 (L= trimethylamine, pyrazine, 4, 4′-bipyridine and N-methyl …

Light irradiation has been used for a long time in several countries as an approved therapy
against cancer in a technique called photodynamic therapy (PDT). Essentially the process …

Phthalocyanine based hybrid nanomaterials show promises in biomedical applications.
However, their lack of solubility in aqueous phase limits their development. This paper aims …

This article reports a strategy to synthesize a hybrid species made of iron phthalocyanine
(FePc) grafted to the surface of silver nanoparticles. The affinity between sulfur and silver on …

Cancer is one of the leading causes of death worldwide. Contemporary therapies do not
achieve the expected effectiveness, the treatment is often non-selective, and its application …